Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Pemetrexed in Pretreated Metastatic Colorectal Cancer
NCT01909830Phase 2Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Jul 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, pemetrexed in metastatic colorectal cancer (mCRC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Jul 2012; status: completed.
02
Drugs
gemcitabinepemetrexed
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01909830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01909830.